Pembrolizumab,Belzutifan,cabozantinib,lenvatinib
Merck,eisai,Exelixis
['thank you']
#esmo22 thank you for a great presentation! #litesaprk011 57% orr no pd no grade 4/5 ae
under belz+cabo in cohort a 
Cancer researcher; Director of GU Cancers @DanaFarber; Prof of Medicine @HarvardMed; ? lover; ??@PanMass
Views are mine.